Dr. Subha Mukherjee, PhD

Scientific Director, Synthetic Molecule Design and Development at Eli Lilly and Company

Speaker

Subha Mukherjee earned his PhD in Chemistry from the University of Illinois at Urbana–Champaign in 2015. He worked under Professor Wilfred A. van der Donk’s supervision in peptide synthesis, bio-orthogonal chemistry, and chemical and enzymatic synthesis to investigate lanthipeptide and phosphonate natural products. In 2015, he joined the process chemistry department at Bristol Myers Squibb Company in New Jersey. There, he transitioned from enabling scalable process development to leading chemistry teams in the peptide, small molecule, and ADC portfolio as a modality-agnostic process chemist. In 2023, he joined Eli Lilly and Company, Indiana, where he is currently a Scientific Director focused on leading innovation in the TIDES space.